djabete: he who suffers from it has one more ally by his side. Her name is Dexcom G7the latest generation technology capable of carrying out the continuous blood glucose monitoring and avoid the greatest fear of diabetics: going into hypo or hyperglycemia and not being able to predict the change in time.
Watch out for inadvertent hypoglycemia
«Hypoglycemia is a constant thought that concerns the majority of the population with diabeteswhich matters about 500 million in the world, 50 in Europe and, according to the Ministry of Health3.5 in Italy. Also alarming is a study among those who suffer from diabetes 1in which over 25% have inadvertent hypoglycemiacondition that increases the risk of degenerating into severe hypoglycemia 6 times. The incidence of severe hypoglycemia in people with type 2 diabetes And equal to 9 cases out of 100 people in a year, but rises to 15 cases in the over 75s.
The time in range
“That ofhypoglycemiasuch as that ofhyperglycemiait’s two o’clock extreme expressions of an imbalance in glucose metabolism in the blood. To keep these levels within optimal limits, the body produces the hormone insulin, which helps cells absorb glucose from the blood. The goal of insulin therapy is to avoid hypo- and hyperglycemiabut above all to maintain a stable glycemic control over timedefined “time in range”i.e. the time of day spent in optimal glycemic range. It is very important to be able to monitor these levels, but it is even more so to be able to do it continuously to have a constant trend in real time every 5 minutes and be alerted in advance whether treatment changes need to be made. The prediction of the datum is the condition for activating a prevention process that can avert the feared complications of inadvertent hypoglycaemia and the risk of serious complication levels, which require the intervention of a third person», explains the Doctor Graziano Di CianniPresident Association of Diabetologists (AMD).
Diabetes and the use of technology
Technology has taken over over time an increasingly central roleas also recommended in the recent ones Guidelines of theHigher Institute of Health for type 1 diabetes. An attention that has also focused on 300 diabetes centres And 500 thousand patients with diabetes at the center of an Italian study, also published in PubMed. It emerges that 40% of patients with type 1 diabetes (over 13 thousand) uses continuous monitoring systemsa percentage that increases for under 18swhich more than a third wear the insulin pump (35%)while more than half (57%) decided to stop using lancing devices for blood glucose measurement to switch to sensor technology mode.
A reliable, accurate and customizable system
The accuracy of the new system Dexcom G7distributed in Italy by Therasit is evident from study published in PubMedentitled: “Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes”. Among the strengths of him the ease of use for the patient, as a simple pressure is enough to wear the device. Among its peculiarities, also theattention to the needs and everyday life of the wearer. It also has customizable alerts (in compliance with safety standards and doctor’s indications), and a refined one digital experience.
Diabetes: improve the life of those who suffer from it
“It’s definitely about an important step if we think of those who suffer from type 1 diabetes and who are proving predisposed to accept solutions that help to improve the quality of life especially among the new generations. Have access to the software they provide data regarding blood glucose trend metrics is improving the approach with patients. There is an evolution between the growing patient demand who want to improve the quality of life and the response from colleagues who want to fulfill this physiological, psychological and even aesthetic need respecting the sustainability and reorganization of the system», concludes Doctor Di Cianni. A further step forward to improve the lives of those living with diabetes.
iO Woman © REPRODUCTION RESERVED